Tag: MM

Find relevant news articles from other European projects, below:

CARAMBA  EURE-CART  CARAT Network ATECT PROCROP T2EVOLVE

Browse our carefully curated library of the latest news and developments in all areas of immunotherapy here:


Onclive4

Should all Elderly Patients with Newly Diagnosed Multiple Myeloma Receive Monoc...

  Nov 25 2020 Tagged MM, mAbs

In light of the recent approvals of combination anti-myeloma regimens containing monoclonal antibodies, as well as the robust pipeline of novel targeted agents likely to be approved in the next year, there is much optimism in the field of multiple myeloma.

Visit website
Onclive1

The Role of Immunotherapy in the Therapeutic Sequencing for Relapsed/Refractory ...

  Nov 08 2020 Tagged MM, mAbs

The treatment landscape of relapsed/ refractory multiple myeloma has undergone rapid changes over the past 2 decades, with over a dozen drug approvals by the FDA.

Visit website
ImmunotherapyWebsite Images Featured 16

Phase III CASSIOPEIA Impacts Treatment Decisions in Patients With Multiple Myelo...

Sonneveld says that not only high-risk patients but all those who are transplant-eligible and newly diagnosed may potentially have a new standard of care in the future.

Visit website